Chronic

Sadly, there's no magic bullet for chronic back pain (yet). However, a new treatment that tackles both psychological and physical limitations has had a remarkable impact on pain relief and mobility, and now therapists hope to roll it out worldwide.

More than 50% of deaths across the globe are from inflammation-related diseases. Now, a breakthrough in immune cell behavior has the potential to treat the condition before it triggers serious health issues such as stroke and heart attack.

A new study has shown that for people with chronic pain taking opioids over the long term, incorporating an internet-based self-management program into treatment may help reduce both pain and opioid intake.

It affects one in nine women, but endometriosis somehow remains undiagnosed for years and hugely misunderstood. Now, scientists have identified 25 new key genetic links to its development and its connection to other chronic pain like migraine.

Persistent lower back pain is a debilitating problem for millions of people around the world and it’s not something that is easily treated, but a technology called Intracept is making waves in this space.

A new study has added to the growing body of evidence reporting similarities between long COVID and chronic fatigue syndrome (ME/CFS). The research found around half of the long COVID patients studied fit the diagnostic criteria for ME/CFS.

A huge new study looking at the symptoms of long COVID in non-hospitalized patients has identified a diverse set of symptoms, including reduced libido and hair loss, and suggested reclassifying the condition into three distinct groups.

Human trials have shown that hydrogel injections are a promising, effective treatment for chronic lower back pain caused by degenerative disc disease (DDD). The treatment is far less invasive than other surgeries, and has been given FDA approval.

A study has presented the most rigorous investigation to date into the long-term cognitive impacts of severe COVID-19. It found persistent cognitive deficits in hospitalized patients equivalent to declines consistent with 20 years of brain aging.

New research has followed the recovery of more than 2,000 hospitalized COVID-19 patients. The findings show barely one in four patients reported feeling fully recovered from COVID-19 a year after being discharged from hospital.

Researchers have discovered a new type of cell in the human lung. Named respiratory airway secretory cells (RASCs), they seem to play a role in regenerating other cells and could be a target for new treatments for lung diseases like COPD.

New research hypothesizes nerve damage is the cause of long COVID symptoms in some people. The small study found treating patients with immunotherapies targeting the neuropathy could improve long COVID symptoms.